NUCLEUS
Nucleus Software Exports Limited
Each stock's 10,000-path forecast, rendered as light.
Nucleus Software Exports Limited (NUCLEUS) Stock Analysis & Case Study
Is NUCLEUS a good buy? The data-driven verdict.
Nucleus Software Exports Limited (NUCLEUS) trades at ₹698,on the numbers it worth a closer look, a Downstox Snapshot Score of 57/100.
On the numbers, Nucleus Software Exports Limited (NUCLEUS) worth a closer look, a Downstox Snapshot Score of 57/100, weighing fairly valued at 16.1× earnings, ROE of 13.1%, a 52% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
NUCLEUS fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How NUCLEUS ranks against the 2,373 companies in our screener
- NUCLEUS's market cap of 1,838 Cr ranks in the 49th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NUCLEUS's book value of ₹345 ranks in the 84th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NUCLEUS's promoter holding of 73.6% ranks in the 85th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NUCLEUS's 3-year revenue growth of 11.0% ranks in the 53rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NUCLEUS's debt-to-equity ratio of 0.01x is lower than 98% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
We do not hold a 3-year profit (PAT) growth figure for NUCLEUS, as of 9 Aug 2026, so it is not ranked here.
Is NUCLEUS overvalued? NUCLEUS P/E vs peers
NUCLEUS trades at 16.1× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
NUCLEUS share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of NUCLEUS history (13%/yr drift, 42%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| NUCLEUS 2027 | ₹410 | ₹715 | ₹1,246 | +2% |
| NUCLEUS 2028 | ₹336 | ₹732 | ₹1,594 | +5% |
| NUCLEUS 2029 | ₹295 | ₹749 | ₹1,906 | +7% |
| NUCLEUS 2030 | ₹260 | ₹767 | ₹2,263 | +10% |
| NUCLEUS 2031 | ₹239 | ₹785 | ₹2,582 | +12% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability NUCLEUS goes up, or doubles?
The bull case for NUCLEUS
- NUCLEUS's P/E of 16.1x is lower than 71% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- NUCLEUS's return on equity of 13.1% ranks in the 64th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,906.
The bear case & risks
- No model or past record guarantees future returns, treat this as one input, not a decision.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹295.
NUCLEUS volatility & expected range, how bumpy is the ride?
Over the last 9.8 years NUCLEUS compounded at 13%/year with annualized volatility of 42%. That volatility implies a 1-year 80% range of ₹410-₹1,246, the honest backbone behind any single price target.
NUCLEUS price forecast, the full 60-month probability fan
NUCLEUS price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds NUCLEUS hits common targets within the simulated horizon?
Full multi-horizon detail on the NUCLEUS price target & forecast page.
NUCLEUS Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. NUCLEUS scores 5/8, mixed financial health.
NUCLEUS MTF margin & leverage across 9 brokers
Margin Trading Facility lets you buy NUCLEUS with part of the capital. Lower margin % = higher leverage. Rates compared across 9 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 34.06% | 2.9× |
| Groww | 34.24% | 2.9× |
| Dhan | 40.00% | 2.5× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 40.17% | 2.5× |
| Pocketful | 34.33% | 2.9× |
| Anand RathiCHEAPEST | 34.06% | 2.9× |
| Bajaj Broking | 45.00% | 2.2× |
| Share India | 34.21% | 2.9× |
Compare every broker on the NUCLEUS MTF page.
About Nucleus Software Exports Limited: sector, index & market-cap context
Nucleus Software Exports Limited (NUCLEUS) is a small-cap NSE-listed company, with a market capitalisation of ₹1,838 Cr. See more stocks on our screener.
How the NUCLEUS Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Nucleus Software Exports Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
NUCLEUS analysis, FAQs
Is Nucleus Software Exports Limited (NUCLEUS) a good buy?
On the numbers, Nucleus Software Exports Limited (NUCLEUS) worth a closer look, a Downstox Snapshot Score of 57/100, weighing fairly valued at 16.1× earnings, ROE of 13.1%, a 52% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is NUCLEUS overvalued or undervalued?
NUCLEUS trades at 16.1× earnings, fairly valued versus the ~22× long-run Nifty average.
What is the NUCLEUS share price target for 2031?
NUCLEUS's probability-weighted 2031 median target is ₹785, with an 80% range of ₹239-₹2,582 (10,000-path Monte-Carlo).
What is the probability NUCLEUS doubles in 5 years?
The modelled probability of NUCLEUS reaching ₹1,397 (2×) within 5 years is 26%.
What is the bull case for NUCLEUS?
NUCLEUS's P/E of 16.1x is lower than 71% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. NUCLEUS's return on equity of 13.1% ranks in the 64th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
What are the risks in NUCLEUS?
No model or past record guarantees future returns, treat this as one input, not a decision.